CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	6 Months Ended		182 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Net Loss	$ (8,804)	$ (6,029)	$ (222,212)
Contributions to capital- expenses			100
Issuance of common stock for expenses			8,700
Depreciation and amortization	170	170	29,160
Change in inventory	407	(384)	(2,047)
Change in accounts payable	6,029	(3,611)	23,682
Net Cash Flows (Used in) Operations	(2,198)	(9,854)	(162,617)
Purchase of patent			(28,650)
Purchase of Equipment-Production Mold			(1,700)
Purchase office equipment			(2,096)
Net Cash Flows (Used in) Investing Activities			(32,446)
Notes Payable from related party	2,285	14,805	63,773
Payments to related party	(87)	(4,791)	(15,422)
Proceeds from issuance of common stock			146,712
Net Cash Flows provided by Financing Activities	2,198	10,014	195,063
Net Change in Cash		160
Cash at End of Period		160
Issuance of 922,900 common shares for a patent- 2000			11,963
Contributions to capital- expenses- 2001			$ 100